Tuesday, March 17, 2026

Inside the Journey of Chef Lee Hasung: From Runner-Up to Opening a Restaurant in NYC!

Chef Lee Hasung shares his journey to opening a New York restaurant on "Chef Ahn Sung-jae," discussing hiring and pre-opening jitters.

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

NVIDIA’s Big Moment: Stock Market Awaits Earnings Surge and Future Outlook

Wall Street's leading beneficiary of generative artificial intelligence (AI), Nvidia, is counting down to its earnings announcement.

Tag: botulinum toxin

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.